12.07.2015 Views

uBvzU

uBvzU

uBvzU

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

RIESGOS DE LOS TRATAMIENTOS36INMUNOMODULADORES YBIOLÓGICOS EN LA EIIBIBLIOGRAFÍA1. Viget N, Vernier-Massouille G, Salmon-Ceron D, Yazdanpanah Y, Colombel JF.Opportunistic infections in patients with inflammatory bowel disease: preventionand diagnosis. Gut. 2008 Apr;57(4):549-58.2. D'Haens G. Risks and benefits of biologic therapy for inflammatory boweldiseases. Gut. 2007 May;56(5):725-32.3. Gisbert JP, Gomollón F. Thiopurine-induced myelotoxicity in patients withinflammatory bowel disease: a review. Am J Gastroenterol. 2008Jul;103(7):1783-800.4. Gisbert JP, González-Lama Y, Maté J. Thiopurine-induced liver injury inpatients with inflammatory bowel disease: a systematic review. Am JGastroenterol. 2007 Jul;102(7):1518-27.ENFERMEDAD INFLAMATORIA INTESTINAL269

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!